Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria
Pathogens · 2025
DOI: 10.3390/pathogens14020169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Vivian N Nwude und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Carver College of Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B virus, Hepatitis B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Luxembourg Ministry of Foreign and European Affairs, Defence, Development Cooperation and Foreign Trade and the Luxembourg Institute of Health, Luxembourg Ministry of Foreign and European Affairs, Defence, Development Cooperation and Foreign Trade.
Abstract (Originalsprache)
Hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality in West Africa, but its presentation is poorly understood. In this study, we describe the clinical characteristics of HBV-associated HCC patients in Lagos, Nigeria. Data for all cases were collected at the emergency and gastroenterology units (2017–2019), considering chronic carriers as controls. Clinical data and routine biochemical and radiologic test results were extracted from the files. The serum biomarkers (Osteopontin, AFP-L3, DCP) were investigated. For some cases, the hepatitis B viral load was determined. The mean age of the cases (n = 92) was 41.4 years, compared to 39.9 years for the controls (n = 100). Clinically, 69.5% of cases presented with ascites, 66.3% had nodules occupying >50% of the liver, and 67.4% had moderate hepatic encephalopathy. The mean viral load and the median values of Osteopontin, AFP-L3, and DCP for the cases were significantly higher than for the controls (p < 0.001). The area under the curve, sensitivity, and specificity were significantly higher for Osteopontin, compared with DCP and AFP-L3 (p < 0.001). Most HCC patients presented at a late disease stage, when the prognosis is usually poor. Especially Osteopontin seems to have potential for early HCC detection and could possibly complement AFP and abdominal ultrasound scan for risk-group screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Carver College of Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.
- Department of Internal Medicine, College of Medicine, University of Lagos, Lagos 12003, Lagos State, Nigeria.
- Lagos State University Teaching Hospital, 1-5 Oba Akinjobi Way, Ikeja 101233, Lagos State, Nigeria.
- Clinical and Applied Virology, Department of Infection and Immunity, Luxembourg Institute of Health, 4354 Esch-sur-Alzette, Luxembourg.
ORCID-Profile: Vivian N Nwude, Charles Onyekwere, Judith M Hübschen
Förderung
- Luxembourg Ministry of Foreign and European Affairs, Defence, Development Cooperation and Foreign Trade and the Luxembourg Institute of Health
- Luxembourg Ministry of Foreign and European Affairs, Defence, Development Cooperation and Foreign Trade
Zitieren
APA
Nwude, V. N., Lesi, O. A., Onyekwere, C., Charpentier, E., & Hübschen, J. M. (2025). Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria. Pathogens. https://doi.org/10.3390/pathogens14020169
Vancouver
Nwude VN, Lesi OA, Onyekwere C, Charpentier E, Hübschen JM. Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria. Pathogens. 2025. doi:10.3390/pathogens14020169
BibTeX
@article{Nwude2025,
author = {Nwude, Vivian N and Lesi, Olufunmilayo A and Onyekwere, Charles and Charpentier, Emilie and Hübschen, Judith M},
title = {Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14020169}
}
EUVIMED